The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa.
about
Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa.Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa.Natural and Genetically Engineered Proteins for Tissue Engineering.Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagenMolecular recognition in the assembly of collagens: terminal noncollagenous domains are key recognition modules in the formation of triple helical protomers.Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.Recombinant Technology in the Development of Materials and Systems for Soft-Tissue Repair.Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy.Clinical features and diagnosis of epidermolysis bullosa acquisita.Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis.Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa.Collagen VII plays a dual role in wound healing.Ultrastructural orientation of laminin 5 in the epidermal basement membrane: an updated model for basement membrane organization.Transient bullous dermolysis of the newborn in three generations.Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen.Dilemmas in distinguishing between dominant and recessive forms of dystrophic epidermolysis bullosa.Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa.CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression.
P2860
Q30650123-033852AF-B8ED-4A0E-A3B0-AD4E4DDBDD8FQ33712943-D66767DE-732E-4659-8E2B-C61003606D87Q34678948-DF65C879-77F0-40E3-8A98-A0CCDCECD509Q35516528-66E7AD91-2F61-48D7-B380-138563176BD6Q36138298-90FCDF6F-6A17-49B7-AA49-9AF22BF1FF2CQ36643333-AA895E2D-5983-4C8E-A693-605CA218BB33Q38383977-570E8ACA-7289-4938-A6F7-5A892E2E9E13Q38546749-A04E9FAF-875C-4E9E-B57C-E7DFA912C8D5Q38772377-34FFBBC1-DCD9-49AF-AE9D-EC45476A5125Q38942490-51199937-B6AF-4687-83BC-BA6E45BCA638Q39599980-1463EC0D-533B-4D35-A0CB-F923B916315DQ40690917-7CC5B220-BD4A-40AC-9715-AF473E1379EEQ41811020-201E3E9B-1A62-4654-8600-83D1AD3E3CB6Q41843053-9274251B-F0C9-459F-A159-765538EE8531Q42450363-0C9E3420-6CE2-4D57-B71E-7F8BBB06760FQ42485297-90071B6D-611A-4E5D-B5D9-D0BAD34B19D3Q43124292-288EC5E1-AB9B-4496-90A4-2887E674C8CCQ44654984-84472B61-7E88-428E-BBD6-EBE45B286E46Q45876048-E99CE879-64DE-40BE-BCEA-B101CA133793Q52346349-D360877B-8EBB-491C-AC1F-0CC6601D5D60
P2860
The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
The recombinant expression of ...... trophic epidermolysis bullosa.
@en
type
label
The recombinant expression of ...... trophic epidermolysis bullosa.
@en
prefLabel
The recombinant expression of ...... trophic epidermolysis bullosa.
@en
P2093
P2860
P356
P1476
The recombinant expression of ...... trophic epidermolysis bullosa.
@en
P2093
Christopher R Lindvay
David T Woodley
Fritz K Costa
Yuan-Ping Han
P2860
P304
P356
10.1074/JBC.M108779200
P407
P577
2001-11-06T00:00:00Z